“…The anticholinesterases are also used to manage other forms of neurological disorders, such as ataxia, PD, dementia with Lewy bodies, senile dementia, vascular dementia, Down's syndrome, Korsakoff disease, and myasthenia gravis (Farmakidis et al, 2018; Kulshreshtha & Piplani, 2016; Mukherjee et al, 2007). Nowadays, there are worldwide research efforts for the design and development of novel cholinesterase inhibitors with more efficacy and fewer side effects (Lotfi et al, 2020; Mariki et al, 2021; Sharma, 2019). The identification of new potent anticholinesterase compounds through the study of natural resources has also attracted a lot of attention (Dey et al, 2017; Dos Santos et al, 2018; Houghton et al, 2006; Mukherjee et al, 2007).…”